Bayesian Mediation Analysis for Neonatal Neurodevelopmental Outcomes in Pregnancy with Opioid Exposure
阿片类药物暴露妊娠期新生儿神经发育结果的贝叶斯中介分析
基本信息
- 批准号:10176650
- 负责人:
- 金额:$ 25.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:6 year oldAlcoholsAnimalsAnxietyAttention deficit hyperactivity disorderAwardBayesian MethodBayesian ModelingBehavioralBirth CertificatesChildChild DevelopmentChildhoodClassificationClinicalCognitiveCongenital AbnormalityDataData AnalysesData SetData SourcesDetectionDevelopmentDevelopmental Delay DisordersEducational AssessmentEducational StatusEnsureExposure toFetal safetyFundingGoalsHealthIncidenceInfant HealthKnowledgeLinkLogistic RegressionsLow Birth Weight InfantMarkov chain Monte Carlo methodologyMaternal ExposureMediatingMediationMediator of activation proteinMedicalMental DepressionMethodsMinorModelingMothersNeonatalNeonatal Abstinence SyndromeNeurologistNewborn InfantOpioidOutcomeOutcome StudyPain managementParentsPathway interactionsPerformancePerinatalPerinatal CarePerinatal ExposurePharmaceutical PreparationsPregnancyPregnant WomenPublic HealthRecordsResearchResearch DesignResearch PersonnelResourcesRiskRoleSafetySample SizeSamplingSignal TransductionSocial SciencesStatistical Data InterpretationStatistical ModelsStructural ModelsTestingTimeUnited StatesWorkadverse outcomeadverse pregnancy outcomeautism spectrum disorderbaseclinically relevantepidemiology studyexperiencefetalfetal opioid exposureflexibilityfollow-upimprovedin uterointerestkindergartenmalformationmaternal opioid usemedication safetymultilevel analysisneonatal outcomeneurobehavioralneurodevelopmentneuron apoptosisobstetric outcomesoffspringopioid exposureopioid overdoseopioid useopioid use in pregnancyoverdose deathprenatal exposureprescription opioidresponsesafety studyscreeningskillsstatisticsthird gradetool
项目摘要
Contact PD/PI: Wen, Xuerong
ABSTRACT
Mediation analysis is useful to quantify the direct and indirect relationship among maternal opioid exposure during
pregnancy, short-term adverse neonatal outcomes, and long-term neurodevelopmental outcomes in children. There are
different approaches to estimate mediation models, and Bayesian methods offer some advantages compared to their
frequentist counterparts: possibility of including prior information, computational feasibility when a multilevel model
structure is needed, and more flexibility in analyzing data with smaller sample sizes. In conducting the originally funded
project (1R15HD097588), we have observed significant effects for pregnancy opioid exposure on multiple short-term
congenital malformations and long-term neurodevelopmental outcomes in children. However, it is unclear whether the
observed effects are direct or indirect, and whether the effect of maternal opioid usage on neonatal development remains
significant after adjusting for mediation factors. The limited data sources restrain our knowledge and creates a formidable
research opportunity. In this project, we will investigate mediation effects of maternal opioid use on multiple short- and
long-term adverse pregnancy outcomes for children. Two linked datasets will be used to examine different outcomes,
provide a long follow-up time, and validate the estimation of pregnancy window. Our findings from the originally
awarded project have shown that prescription opioid use in pregnant women is associated with increased risk of
congenital malformations and neonatal neurodevelopmental outcomes. It is necessary to further adjust for the mediation
factors and determine the direct effects of opioid exposure during pregnancy. The focus of this project is to study the
relationship between perinatal opioid exposure and adverse health outcomes in children. We hypothesize that prescription
opioid use during pregnancy directly poses risks on long-term development of children, and that optimized pain
management in pregnant women improves long-term health outcomes for children. Specific Aim 1: To identify the
mediation factors that are on the causal pathway of maternal exposure to prescription opioids and neonatal
neurodevelopmental outcomes. The goal of this aim is to identify the mediators that are significantly associated with
maternal opioid exposure and also strongly correlated with child long-term neurodevelopmental outcomes. First, we will
fit a multivariable logistic regression model to assess the association between short-term adverse neonatal outcomes and
in-utero opioid exposure after adjusting for baseline potential confounding factors. Second, parametric and non-parametric
correlations will be assessed for long-term neurodevelopmental outcomes and short-term adverse neonatal outcomes that
are significantly related to in-utero opioid exposure. Third, a mediating risk scores will be calculated based on all selected
mediators. Specific Aim 2: To formulate and estimate a Bayesian mediation model for the long-term neonatal
neurodevelopmental outcome First, we will formulate a Bayesian mediation analysis model. The specification of a
Bayesian mediation model requires the prior distribution elicitation for the unknown parameters, using information from
previous studies when available, and a sampling distribution for the response or mediation variable. The choice of default
priors allows for comparison with frequentist methods. Second, Markov Chain Monte Carlo methods (MCMC) will be
applied to estimate Bayesian models. Posterior distributions will be obtained for all the parameters of interest, in particular
for the effect of maternal opioid exposure during pregnancy. Posterior distribution analysis allows for the extraction of
summary statistics of interest, posterior means, medians, and credible intervals. Robustness of results will be assessed for
different prior distribution choices.
Outcome: This work will significantly impact the field of opioid safety in pregnancy by accurately quantifying the
association between perinatal exposure to prescription opioids with long term neurodevelopment and educational status in
children.
Project Summary/Abstract
联系PD/PI:Wen,Xuerong
抽象的
调解分析对于量化母体阿片类药物之间的直接和间接关系很有用
怀孕,短期不良新生儿结局以及儿童的长期神经发育结局。有
估计调解模型的不同方法,贝叶斯方法与其相比提供了一些优势
频繁的对应物:包括先前信息,计算可行性时的可能性
需要结构,并且在分析样本量较小的数据方面具有更大的灵活性。在进行原始资助的
项目(1R15HD097588),我们观察到对妊娠阿片类药物对多个短期的显着影响
儿童的先天性畸形和长期神经发展结果。但是,目前尚不清楚是否
观察到的影响是直接或间接的,以及产妇使用对新生儿发育的影响是否仍然存在
调整调解因子后有效。有限的数据来源限制了我们的知识,并创造了强大的知识
研究机会。在该项目中,我们将研究产妇使用阿片类药物对多个短期和多个短期和
儿童的长期不良怀孕结局。两个链接的数据集将用于检查不同的结果,
提供长时间的随访时间,并验证妊娠窗口的估计。我们最初的发现
授予的项目表明,孕妇的处方阿片类药物使用与增加的风险有关
先天性畸形和新生儿神经发育结果。有必要进一步调整调解
因素并确定怀孕期间阿片类药物的直接影响。该项目的重点是研究
儿童围产期阿片类药物暴露与不良健康结果之间的关系。我们假设处方
怀孕期间的阿片类药物使用直接对儿童的长期发育构成风险,并优化
孕妇的管理改善了儿童的长期健康状况。特定目标1:确定
孕产妇暴露于处方阿片类药物和新生儿的因果途径上的调解因子
神经发育结果。该目标的目的是确定与与之显着相关的调解人
孕产妇阿片类药物暴露,并且与儿童长期神经发育结局密切相关。首先,我们会的
拟合多变量的逻辑回归模型,以评估短期不良新生儿结果与
调整基线潜在混杂因素后,utero阿片类药物的暴露。其次,参数和非参数
将评估长期神经发育结果和短期不良新生儿结局的相关性
与局内阿片类药物暴露显着相关。第三,将根据所有选定
调解人。特定目的2:为长期新生儿制定和估计贝叶斯调解模型
神经发育结果首先,我们将制定贝叶斯调解分析模型。一个规格
贝叶斯调解模型需要使用来自未知参数的先验分布启发
先前的研究,以及用于响应或中介变量的抽样分布。默认的选择
先验可以与频繁的方法进行比较。其次,马尔可夫链蒙特卡洛方法(MCMC)将是
应用于估计贝叶斯模型。对于所有感兴趣的参数,将获得后验分布,特别是
为了在怀孕期间孕产妇阿片类药物暴露的影响。后验分配分析允许提取
摘要的统计数据,后验,中值和可靠的间隔。结果的鲁棒性将被评估
不同的先前分发选择。
结果:这项工作将通过准确量化怀孕的阿片类药物安全领域,从而显着影响
围产期暴露于处方阿片类药物具有长期神经发育和教育状况之间的关联
孩子们。
项目摘要/摘要
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study.
- DOI:10.1007/s40264-021-01080-0
- 发表时间:2021-08
- 期刊:
- 影响因子:4.2
- 作者:Wen X;Lawal OD;Belviso N;Matson KL;Wang S;Quilliam BJ;Meador KJ
- 通讯作者:Meador KJ
A Bayesian latent class model for predicting gestational age in health administrative data.
- DOI:10.1002/pst.2225
- 发表时间:2022-11
- 期刊:
- 影响因子:1.5
- 作者:Wang, Shuang;Puggioni, Gavino;Wen, Xuerong
- 通讯作者:Wen, Xuerong
Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
- DOI:10.1001/jamanetworkopen.2021.5708
- 发表时间:2021-04-01
- 期刊:
- 影响因子:13.8
- 作者:Wen X;Belviso N;Murray E;Lewkowitz AK;Ward KE;Meador KJ
- 通讯作者:Meador KJ
Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural Models.
- DOI:10.1007/s40264-021-01115-6
- 发表时间:2021-12
- 期刊:
- 影响因子:4.2
- 作者:Wen X;Wang S;Lewkowitz AK;Ward KE;Brousseau EC;Meador KJ
- 通讯作者:Meador KJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuerong Wen其他文献
Xuerong Wen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:82274386
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于斑马鱼模型研究异甘草酸镁对酒精性肝损伤的保护作用机制
- 批准号:81900534
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
Protectin DX对非酒精性脂肪性肝病的保护作用及其机制研究
- 批准号:81860161
- 批准年份:2018
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
DNA修复酶家族成员TiPARP在非酒精性脂肪性肝病早期的作用及机制
- 批准号:81873568
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
7596434 - 财政年份:2002
- 资助金额:
$ 25.67万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
7799130 - 财政年份:2002
- 资助金额:
$ 25.67万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
8249782 - 财政年份:2002
- 资助金额:
$ 25.67万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
8055575 - 财政年份:2002
- 资助金额:
$ 25.67万 - 项目类别:
Nutritional Effects On Essential Fatty Acid Composition
营养对必需脂肪酸组成的影响
- 批准号:
9155430 - 财政年份:
- 资助金额:
$ 25.67万 - 项目类别: